VLDL receptor gene therapy for reducing atherogenic lipoproteins

Over the past 40 years, there has been considerable research into the management and treatment of atherogenic lipid disorders. Although the majority of treatments and management strategies for cardiovascular disease (CVD) center around targeting low-density lipoprotein cholesterol (LDL-C), there is...

詳細記述

書誌詳細

出版年:	Molecular Metabolism
主要な著者:	Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2023-03-01
主題:	Lipid disorders VLDL VLDL receptor Triglycerides lipoprotein(a) Gene therapy
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2212877823000194